LSA
NVO

L & S Advisors’s Novo Nordisk NVO Stock Holding History

L & S Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-63,072
Closed -$9M – 365
2024
Q2 		$9M Sell
63,072
-3,114
-5% -$413K 1.03% 23
2024
Q1 		$8.5M Buy
66,186
+648
+1% +$77.1K 0.96% 28
2023
Q4 		$6.78M Sell
65,538
-24,288
-27% -$2.4M 0.83% 36
2023
Q3 		$8.17M Buy
+89,826
New +$7.91M 1.17% 18
2021
Q4 		– Sell
-16,610
Closed -$797K – 332
2021
Q3 		$797K Buy
+16,610
New +$803K 0.09% 211

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

L & S Advisors's NVO Position: Q3 2024 in Review

L & S Advisors sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 63,072 shares — an estimated $9M sold.

L & S Advisors first reported a position in NVO in Q3 2021 and held it in 5 quarters. The position peaked at $9M in Q2 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • L & S Advisors reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • L & S Advisors sold 63,072 Novo Nordisk shares in Q3 2024, an estimated $9M.
  • L & S Advisors first reported a position in Novo Nordisk in Q3 2021 and held it in 5 quarters.
  • L & S Advisors's Novo Nordisk position peaked at $9M in Q2 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on L & S Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.